TWTimothy A. Whitehead

Timothy A. Whitehead

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Timothy A. Whitehead has a total of 164 co-authors. Here are the top co-authors by number of shared publications:

  • Paul J. Steiner

    Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, USA

    8 shared publications
  • Zachary T. Baumer

    Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, USA

    8 shared publications
  • Brian M. Petersen

    Department of Chemical and Biological Engineering, University of Colorado

    6 shared publications
  • Emily R. Rhodes

    Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, USA

    6 shared publications
  • Ian Wheeldon

    Chemical and Environmental Engineering, University of California, Riverside, CA 92521, USA

    6 shared publications
  • Sean R. Cutler

    Institute of Integrative Genome Biology University of California, Riverside Riverside CA USA

    6 shared publications

Latest Publications

  • Protein Engineering of a Genetically Encodable Biosensor for Wastewater Detection of Profen NSAIDs

    by Zoë Davis, Hao Tian, Ian R. Wheeldon, Sean R. Cutler, Timothy A. Whitehead

    Non‐steroidal anti‐inflammatory drugs (NSAIDs) are pervasive environmental contaminants due to their frequent and widespread use, multiple paths of release into surface and ground water supply, diversity of the chemical class, and toxicity to aquatic and other non‐target species. In particular, the 2‐arylpropionic acid (“profen”) class of NSAIDs poses significant risks to aquatic ecosystems due to incomplete removal during wastewater treatment. Current monitoring precludes high‐frequency testing at point sources. Here, we present the engineering and application of a genetically encodable, protein‐based biosensor for the detection of the NSAIDs ketoprofen and pranoprofen in wastewater effluent. We repurposed the plant hormone receptor PYR1 to bind selectively to profens using computational protein design, deep mutational scanning, and yeast 2‐hybrid and yeast surface display screening. The resulting sensor, PYR1 NSAID , has a nanomolar limit of detection for ketoprofen and panoprofen, and µM sensitivity to the NSAIDs ibuprofen, fenoprofen, tolmetin and diclofenac. We also demonstrated dose‐responsive activity of our sensor in simulated wastewater matrices containing the common wastewater contaminants sulfamethoxazole, caffeine, acetaminophen, and 2,4‐dichlorophenol using a split Nanoluc luminescence assay. PYR1 NSAID is the first step towards a scalable, cost‐effective alternative for real‐time monitoring of pharmaceutical pollution.


  • Open Access

    Protein engineering of a genetically encoded biosensor for wastewater detection of profen NSAIDs

    by Zoë Davis, Hao Tian, Ian Wheeldon, Sean R. Cutler, Timothy A. Whitehead

    Non-steroidal anti-inflammatory drugs (NSAIDs) are pervasive environmental contaminants due to their frequent and widespread use, multiple paths of release into surface and ground water supply, diversity of the chemical class, and toxicity to aquatic and other non-target species. In particular, the 2-arylpropionic acid (“profen”) class of NSAIDs poses significant risks to aquatic ecosystems due to incomplete removal during wastewater treatment. Current monitoring precludes high frequency testing at point sources. Here we present the engineering and application of a genetically encodable, protein-based biosensor for the detection of the NSAIDs ketoprofen and pranoprofen in wastewater effluent. We repurposed the plant hormone receptor PYR1 to bind selectively to profens using computational protein design, deep mutational scanning, and yeast 2 hybrid and yeast surface display screening. The resulting sensor, PYR NSAID , has a nanomolar limit of detection for ketoprofen and panoprofen, and µM sensitivity to the NSAIDs ibuprofen, fenoprofen, tolmetin and diclofenac. We also demonstrated dose responsive-activity of our sensor in simulated wastewater matrices containing the common wastewater contaminants sulfamethoxazole, caffeine, acetaminophen, and 2,4, dichlorophenol using a split Nanoluc luminescence assay. PYR NSAID is the first step towards a scalable, cost-effective alternative for real-time monitoring of pharmaceutical pollution.

  • Open Access

    Computational redesign of a thermostable T7 RNA polymerase

    by Zachary T Baumer, Timothy A Whitehead

    T7 RNA polymerase (T7 RNAP) is a foundational enzyme for biotechnology, but its utility for many potential applications is limited by low thermal stability of 43–44°C. While stabilized variants exist, the most stable commercial version has a proprietary sequence. In this work we developed a highly stable T7 RNAP using structure-based computational design. We combined mutations from previous stabilized variants (M5, M8, V7abcd) with new mutations identified by PROSS. These mutations were filtered using data-driven heuristics to preserve function. Our final design, T7T+, contains 30 point mutations from the original T7 RNAP and demonstrates a functional stability (T50) of 54.9°C in a thermal challenge assay, which is 2.4°C higher than the most stable, published open-source variant to date. Circular dichroism spectroscopy showed an apparent melting temperature of 53.8°C. T7T+ retains 59% of wild-type activity at 37°C. 16 of the 18 tested protein designs had higher stability against thermal challenge compared with the genetic background, attesting to the high success rates of existing non deep learning computational methods for the design of stable, functional proteins. A plasmid encoding T7T+ has been deposited in AddGene and is freely available for non-commercial use.

  • Top Cited Papers
    Open Access

    Computational design of dynamic biosensors for emerging synthetic opioids

    by Alison C. Leonard, Chase Lenert-Mondou, Rachel Chayer, Samuel Swift, Zachary T. Baumer, Ryan Delaney, Anika J. Friedman, Nicholas R. Robertson, Norman Seder, Jordan Wells, et al.

    Nitazenes are an emergent class of synthetic opioids that often rival or exceed fentanyl in their potency. These compounds have been detected internationally in illicit drugs and are the cause of increasing numbers of hospitalizations and overdoses. New analogs are consistently released, making detection challenging — new ways of testing a wide range of nitazenes and their metabolic products are urgently needed. Here, we develop a computational protocol to redesign the plant abscisic acid receptor PYR1 to bind diverse nitazenes and maintain its dynamic transduction mechanism. The best design has a low nanomolar limit of detection in vitro against nitazene and menitazene. Deep mutational scanning yielded sensors able to recognize a range of clinically relevant nitazenes and the common metabolic byproduct in a complex biological matrix with limited cross-specificity against unrelated opioids. Application of protein design tools on privileged receptors like PYR1 may yield general sensors for a wide range of applications in vitro and in vivo.


  • Open Access

    Computational design of dynamic biosensors for emerging synthetic opioids

    by Alison C. Leonard, Chase Lenert-Mondou, Rachel Chayer, Samuel Swift, Zachary T. Baumer, Ryan Delaney, Anika Jane Friedman, Nicholas R. Robertson, Norman Seder, Jordan T Wells, et al.

    Nitazenes are an emergent class of synthetic opioids that rival or exceed fentanyl in their potency. These compounds have been detected internationally in illicit drugs and are the cause of increasing numbers of hospitalizations and overdoses. New analogs are consistently released, making detection challenging – new ways of testing a wide range of nitazenes and their metabolic products are urgently needed. Here, we developed a computational protocol to redesign the plant abscisic acid receptor PYR1 to bind diverse nitazenes and maintain its dynamic transduction mechanism. The best design has a low nanomolar limit of detection in vitro against nitazene and menitazene. Deep mutational scanning yielded sensors able to recognize a range of clinically relevant nitazenes and the common metabolic byproduct in complex biological matrices with limited cross-specificity against unrelated opioids. Application of protein design tools on privileged receptors like PYR1 may yield general sensors for a wide range of applications in vitro and in vivo .


  • Open Access

    Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive

    by Monica B. Kirby, Brian M. Petersen, Jonathan G. Faris, Siobhan P. Kells, Kayla G. Sprenger, Timothy A. Whitehead

    Immunological interventions, like vaccinations, are enabled by the predictive control of humoral responses to novel antigens. While the development trajectories for many broadly neutralizing antibodies (bnAbs) have been measured, it is less established how human subtype-specific antibodies develop from their precursors. In this work, we evaluated the retrospective development trajectories for eight anti-SARS-CoV-2 Spike human antibodies (Abs). To mimic the immunological process of BCR selection during affinity maturation in germinal centers (GCs), we performed deep mutational scanning on anti-S1 molecular Fabs using yeast display coupled to fluorescence-activated cell sorting. Focusing only on changes in affinity upon mutation, we found that human Ab development pathways have few mutations which impart changes in monovalent binding dissociation constants and that these mutations can occur in nearly any order. Maturation pathways of two bnAbs showed that while they are only slightly less permissible than subtype-specific Abs, more development steps on average are needed to reach the same level of affinity. Many of the subtype-specific Abs had inherent affinity for antigen, and these results were robust against different potential inferred precursor sequences. To evaluate the effect of differential affinity for precursors on GC outcomes, we adapted a coarse-grained affinity maturation model. This model showed that antibody precursors with minimal affinity advantages rapidly outcompete competitors to become the dominant clonotype.


  • Engineered Stop and Go T7 RNA Polymerases

    by Zachary T. Baumer, Matilda S. Newton, Lina Löfstrand, Genesis Nicole Carpio Paucar, Natalie G. Farny, Timothy A. Whitehead

    Precise, stringent, post-translational activation of enzymes is essential for many synthetic biology applications. For example, even a few intracellular molecules of unregulated T7 RNA polymerase can result in growth cessation in a bacterium. We sought to mimic the properties of natural enzymes, where activity is regulated ubiquitously by endogenous metabolites. Here we demonstrate that full-length, single subunit T7-derived RNA polymerases (T7 RNAP) can be activated by physiologically relevant concentrations of indoles. We used rational design and directed evolution to identify T7 RNAP variants with minimal transcriptional activity in the absence of indole, and a 29-fold increase in activity with an EC50 of 344 mu M. Indoles control T7-dependent gene expression exogenously, endogenously, and between cells. We also demonstrate indole-dependent bacteriophage viability and propagation in trans. Specificity of different indoles, T7 promoter specificities, and portability to different bacteria are shown. Our ligand activated RNA polymerases (LARPs) represent a new chemically inducible "stop and go" platform immediately deployable for novel synthetic biology applications, including for modulation of synthetic cocultures.


  • Open Access

    in vitro analysis of a competitive inhibition model for T7 RNA polymerase biosensors

    by Ryan M. Delaney, Katherine A. Lamb, Olivia M. Irivin, Zachary T. Baumer, Timothy A. Whitehead

    T7 RNA polymerase (T7 RNAP) biosensors, in which T7 RNAP transcribes some reporter gene or signal in response to external stimuli, have wide applications in synthetic biology and metabolic engineering. We adapted a biochemical reaction network model and used an in vitro transcription assay to determine network parameters for different T7 RNAP constructs. Under conditions where template DNA is limiting, the EC 50 values of native and engineered T7 RNAPs ranged from 33 nM (29 -37 95% c.i.) to 570 nM (258 -714 95% c.i.) (wild-type T7 RNAP). The measured EC 50 values were largely insensitive to free magnesium, pH, or other buffer conditions. Many biosensor configurations use a split RNAP construct, where the C-terminal (CT7) and N-terminal T7 (NT7) are fused to proximity induced dimerization modules. We used proteolysis and ion exchange chromatography to prepare a CT7 (80 kDa) product. The impact of free CT7 on T7 RNAP transcriptional activity was well described by a competitive inhibition model, with an inhibitory constant K I = 24 nM (22-26 95% c.i.) of the sensor. These model parameters will be useful for forward modeling and design of T7 RNAP-based genetic circuits. Highlights: EC 50 values for natural and engineered T7 RNAPs measured in vitro C-terminal T7 RNAP is a competitive inhibitor of full-length T7 RNAP The inhibition constant of C-terminal T7 RNAP is lower than the EC 50 of T7 RNAP

  • Open Access

    Dynamic regulation of engineered T7 RNA polymerases by endogenous metabolites

    by Zachary T. Baumer, Matilda Newton, Lina Löfstrand, Genesis Nicole Carpio Paucar, Natalie G. Farny, Timothy A. Whitehead

    For many enzymes, activity is regulated post-translationally by endogenous metabolites. Designing liganded control of essential activities like transcription would advance predictive control of biological processes, a fundamental goal of synthetic biology. Here we demonstrate that full-length, single subunit T7-derived RNA polymerases (T7 RNAP) can be controlled by physiologically relevant concentrations of indoles. We used rational design and directed evolution to identify T7 RNAP variants with minimal transcriptional activity in the absence of indole, and a 29-fold increase in activity with an EC 50 of 344 µ M. Indoles control T7-dependent gene expression exogenously, endogenously, and inter-cellularly. We also demonstrate indole-dependent bacteriophage viability and propagation in trans . Specificity of different indoles, T7 promoter specificities, and portability to different bacteria are shown. Our l igand a ctivated R NA p olymerases (LARPs) represent a new chemically inducible platform immediately deployable for novel synthetic biology applications, including for modulation of synthetic co-cultures.


  • Rationalizing Diverse Binding Mechanisms to the Same Protein Fold: Insights for Ligand Recognition and Biosensor Design

    by Alison C. Leonard, Anika J. Friedman, Rachel Chayer, Brian M. Petersen, Janty Woojuh, Zenan Xing, Sean R. Cutler, Joel L. Kaar, Michael R. Shirts, Timothy A. Whitehead

    The engineering of novel protein-ligand binding interactions, particularly for complex drug-like molecules, is an unsolved problem, which could enable many practical applications of protein biosensors. In this work, we analyzed two engineered biosensors, derived from the plant hormone sensor PYR1, to recognize either the agrochemical mandipropamid or the synthetic cannabinoid WIN55,212-2. Using a combination of quantitative deep mutational scanning experiments and molecular dynamics simulations, we demonstrated that mutations at common positions can promote protein-ligand shape complementarity and revealed prominent differences in the electrostatic networks needed to complement diverse ligands. MD simulations indicate that both PYR1 protein-ligand complexes bind a single conformer of their target ligand that is close to the lowest free-energy conformer. Computational design using a fixed conformer and rigid body orientation led to new WIN55,212-2 sensors with nanomolar limits of detection. This work reveals mechanisms by which the versatile PYR1 biosensor scaffold can bind diverse ligands. This work also provides computational methods to sample realistic ligand conformers and rigid body alignments that simplify the computational design of biosensors for novel ligands of interest.